Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Hepatitis B (rDNA) 20micrograms/1ml vacc inj pfs
1404000G0AAACAC
|
Hepatitis B | Hepatitis B | Immunological Products and Vaccines | 140 |
|
Hepatitis B (rDNA) 10micrograms/0.5ml vacc inj pfs
1404000G0AAAIAI
|
Hepatitis B | Hepatitis B | Immunological Products and Vaccines | 66 |
|
Hepatitis B (rDNA) 20micrograms/0.5ml vacc inj pfs
1404000G0AAAJAJ
|
Hepatitis B | Hepatitis B | Immunological Products and Vaccines | 43 |
|
Hepatitis B (rDNA) 40micrograms/1ml vacc inj vials
1404000G0AAAGAG
|
Hepatitis B | Hepatitis B | Immunological Products and Vaccines | 21 |
|
Hepatitis B (rDNA) 5micrograms/0.5ml vacc inj pfs
1404000G0AAAFAF
|
Hepatitis B | Hepatitis B | Immunological Products and Vaccines | 20 |
|
Hepatitis B (rDNA) 10micrograms/1ml vacc inj pfs
1404000G0AAAEAE
|
Hepatitis B | Hepatitis B | Immunological Products and Vaccines | 9 |
|
Hepatitis B (rDNA) 20micrograms/1ml vacc inj vials
1404000G0AAABAB
|
Hepatitis B | Hepatitis B | Immunological Products and Vaccines | 1 |
|
Hep B vacc (recmb, ads) 10microg/1ml inj vials
1404000G0AAAKAK
|
Hepatitis B | Hepatitis B | Immunological Products and Vaccines | No data available |
|
Hepatitis B (rDNA) 10micrograms/0.5ml vacc inj vials
1404000G0AAAAAA
|
Hepatitis B | Hepatitis B | Immunological Products and Vaccines | No data available |
|
Hepatitis B (rDNA) 10micrograms/1ml vacc inj vials
1404000G0AAADAD
|
Hepatitis B | Hepatitis B | Immunological Products and Vaccines | No data available |
|
Hepatitis B (rDNA) 5micrograms/0.5ml vacc inj vials
1404000G0AAAHAH
|
Hepatitis B | Hepatitis B | Immunological Products and Vaccines | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.